The Effect of Rate Control on Quality of Life in Patients With Permanent Atrial Fibrillation Data From the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) Study

被引:107
作者
Groenveld, Hessel F.
Crijns, Harry J. G. M. [2 ]
Van den Berg, Maarten P.
Van Sonderen, Eric [3 ]
Alings, A. Marco [4 ]
Tijssen, Jan G. P. [5 ]
Hillege, Hans L. [6 ]
Tuininga, Ype S. [7 ]
Van Veldhuisen, Dirk J.
Ranchor, Adelita V. [3 ]
Van Gelder, Isabelle C. [1 ,8 ]
机构
[1] Univ Groningen, Dept Cardiol, Thoraxctr, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands
[2] Maastricht Univ Med Ctr, Maastricht, Netherlands
[3] Univ Med Ctr Groningen, Dept Hlth Sci, NL-9713 AV Groningen, Netherlands
[4] Amphia Hosp, Breda, Netherlands
[5] Univ Amsterdam, Acad Ctr, Amsterdam, Netherlands
[6] Univ Med Ctr Groningen, Trial Coordinat Ctr, Dept Epidemiol, NL-9713 AV Groningen, Netherlands
[7] Deventer Hosp, Deventer, Netherlands
[8] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands
关键词
atrial fibrillation; quality of life; rate control; STRICT RATE CONTROL; ELECTRICAL CARDIOVERSION RACE; GENDER-RELATED DIFFERENCES; RHYTHM MANAGEMENT AFFIRM; SF-36 HEALTH SURVEY; EURO HEART SURVEY; TASK-FORCE; FATIGUE; LENIENT; IMPAIRMENT;
D O I
10.1016/j.jacc.2011.06.055
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The aim of this study was to investigate the influence of rate control on quality of life (QOL). Background The RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) trial showed that lenient rate control is not inferior to strict rate control in terms of cardiovascular morbidity and mortality. The influence of stringency of rate control on QOL is unknown. Methods In RACE II, a total of 614 patients with permanent atrial fibrillation (AF) were randomized to lenient (resting heart rate [HR] <110 beats/min) or strict (resting HR <80 beats/min, HR during moderate exercise <110 beats/min) rate control. QOL was assessed in 437 patients using the Medical Outcomes Study 36-item Short-Form Health Survey (SF-36) questionnaire, AF severity scale, and Multidimensional Fatigue Inventory-20 (MFI-20) at baseline, 1 year, and end of study. QOL changes were related to patient characteristics. Results Median follow-up was 3 years. Mean age was 68 +/- 8 years, and 66% were males. At the end of follow-up, all SF-36 subscales were comparable between both groups. The AF severity scale was similar at baseline and end of study. At baseline and at end of study there were no differences in the MFI-20 subscales between the 2 groups. Symptoms at baseline, younger age, and less severe underlying disease, rather than assigned therapy or heart rate, were associated with QOL improvements. Female sex and cardiovascular endpoints during the study were associated with worsening of QOL. Conclusions Stringency of heart rate control does not influence QOL. Instead, symptoms, sex, age, and severity of the underlying disease influence QOL. (Rate Control Efficacy in Permanent Atrial Fibrillation; NCT00392613) (J Am Coll Cardiol 2011;58:1795-803) (C) 2011 by the American College of Cardiology Foundation
引用
收藏
页码:1795 / 1803
页数:9
相关论文
共 34 条
[1]   Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations [J].
Aaronson, NK ;
Muller, M ;
Cohen, PDA ;
Essink-Bot, ML ;
Fekkes, M ;
Sanderman, R ;
Sprangers, MAG ;
Velde, AT ;
Verrips, E .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (11) :1055-1068
[2]   Effect of continuous versus episodic amiodarone treatment on quality of life in persistent atrial fibrillation [J].
Ahmed, Sheba ;
Ranchor, Adelita V. ;
Crijns, Harry J. G. M. ;
Van Veldhuisen, Dirk J. ;
Van Gelder, Isabelle C. .
EUROPACE, 2010, 12 (06) :785-791
[3]   Cancer-related fatigue in patients attending oncological rehabilitation programs: Prevalence, patterns and predictors [J].
Bartsch, HH ;
Weis, J ;
Moser, MT .
ONKOLOGIE, 2003, 26 (01) :51-57
[4]   Rate control in atrial fibrillation - Choice of treatment and assessment of efficacy [J].
Boriani, G ;
Biffi, M ;
Diemberger, I ;
Martignani, C ;
Branzi, A .
DRUGS, 2003, 63 (14) :1489-1509
[5]   VALIDATING THE SF-36 HEALTH SURVEY QUESTIONNAIRE - NEW OUTCOME MEASURE FOR PRIMARY CARE [J].
BRAZIER, JE ;
HARPER, R ;
JONES, NMB ;
OCATHAIN, A ;
THOMAS, KJ ;
USHERWOOD, T ;
WESTLAKE, L .
BMJ-BRITISH MEDICAL JOURNAL, 1992, 305 (6846) :160-164
[6]  
Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]
[7]   A POWER PRIMER [J].
COHEN, J .
PSYCHOLOGICAL BULLETIN, 1992, 112 (01) :155-159
[8]   Relation between achieved heart rate and outcomes in patients with atrial fibrillation - (from the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] study) [J].
Cooper, HA ;
Bloomfield, DA ;
Bush, DE ;
Katcher, MS ;
Rawlins, M ;
Sacco, JD ;
Chandler, M .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (10) :1247-1253
[9]   Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe -: A report from the Euro Heart Survey on atrial fibrillation [J].
Dagres, Nikolaos ;
Nieuwlaat, Robby ;
Vardas, Panos E. ;
Andresen, Dietrich ;
Levy, Samuel ;
Cobbe, Stuart ;
Kremastinos, Dimitrios Th. ;
Breithardt, Guenter ;
Cokkinos, Dennis V. ;
Crijns, Harry J. G. M. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (05) :572-577
[10]   The impairment of health-related quality of life in patients with intermittent atrial fibrillation: Implications for the assessment of investigational therapy [J].
Dorian, P ;
Jung, W ;
Newman, D ;
Paquette, M ;
Wood, K ;
Ayers, GM ;
Camm, J ;
Akhtar, M ;
Luderitz, B .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (04) :1303-1309